Santa Fe, New Mexico — April 15, 2026 — Litmys, a life sciences commercial strategy consulting firm, specializing in the development of commercial readiness analytics, and Konovo, a technology-first healthcare intelligence company that accelerates access to customer insights across the healthcare ecosystem, today announced a partnership that will transform how life sciences companies make earlier, smarter, and more commercially informed R&D investment and clinical development decisions.

Santa Fe, New Mexico — April 7th, 2026 — Litmys, a life sciences commercial strategy firm, today announced the launch of RAMPx (Realistic Assessment of Market Potential), a 12-factor scoring model designed to help  life sciences companies identify and mitigate commercial risk earlier in the product development process, especially since about 50% of new products achieve clinical and regulatory success but underperform financially in the market.

Santa Fe, New Mexico — November 24, 2025 — Litmys, a newly launched life sciences consulting firm, today unveiled its groundbreaking approach to product development risk assessment, an evidence-driven model that enables pharmaceutical, biotechnology, diagnostic, and medical device companies to make earlier, smarter, and commercially informed R&D investment decisions.